262 related articles for article (PubMed ID: 12923577)
1. Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2.
Winkler A; Kremer Hovinga JA; Bianchi V; Studt JD; Lämmle B
Hamostaseologie; 2003 Aug; 23(3):103-8. PubMed ID: 12923577
[TBL] [Abstract][Full Text] [Related]
2. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
[TBL] [Abstract][Full Text] [Related]
5. [Thrombotic microangiopathy: thrombocytopenia and hemolytic anemia].
Kater AP; van der Lelie J; Levi M
Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2343-7. PubMed ID: 12510396
[TBL] [Abstract][Full Text] [Related]
6. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
Saha M; McDaniel JK; Zheng XL
J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of thrombotic thrombocytopenic purpura.
Raife TJ
Curr Hematol Rep; 2003 Mar; 2(2):133-8. PubMed ID: 12901144
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor and thrombotic thrombocytopenic purpura.
Raife TJ; Montgomery RR
Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
[TBL] [Abstract][Full Text] [Related]
11. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM
Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL
Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
16. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
Robertson MD; Zumberg M
Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
Marques MB; Mayfield CA; Blackall DP
Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
[TBL] [Abstract][Full Text] [Related]
18. [TTP/HUS and VWF/ADAMTS-13].
Fujimura Y
Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
[No Abstract] [Full Text] [Related]
19. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
20. Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy.
Forman RB; Benkel SA; Novik Y; Tsai HM
Acta Haematol; 2003; 109(3):150-2. PubMed ID: 12714826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]